Genome-wide discovery of somatic regulatory variants in diffuse large B-cell lymphoma SE Arthur, A Jiang, BM Grande, M Alcaide, R Cojocaru, CK Rushton, ... Nature communications 9 (1), 1-14, 2018 | 147 | 2018 |
The double-hit signature identifies double-hit diffuse large B-cell lymphoma with genetic events cryptic to FISH LK Hilton, J Tang, S Ben-Neriah, M Alcaide, A Jiang, BM Grande, ... Blood, The Journal of the American Society of Hematology 134 (18), 1528-1532, 2019 | 104 | 2019 |
Super-enhancer hypermutation alters oncogene expression in B cell lymphoma E Bal, R Kumar, M Hadigol, AB Holmes, LK Hilton, JW Loh, K Dreval, ... Nature 607 (7920), 808-815, 2022 | 82 | 2022 |
Genetic and evolutionary patterns of treatment resistance in relapsed B-cell lymphoma CK Rushton, SE Arthur, M Alcaide, M Cheung, A Jiang, KM Coyle, ... Blood advances 4 (13), 2886-2898, 2020 | 80 | 2020 |
The kinases LF4 and CNK2 control ciliary length by feedback regulation of assembly and disassembly rates LK Hilton, K Gunawardane, JW Kim, MC Schwarz, LM Quarmby Current Biology 23 (22), 2208-2214, 2013 | 67 | 2013 |
Centrioles are freed from cilia by severing prior to mitosis JDK Parker, LK Hilton, DR Diener, M Qasim Rasi, MR Mahjoub, ... Cytoskeleton 67 (7), 425-430, 2010 | 66 | 2010 |
Genetic subgroups inform on pathobiology in adult and pediatric Burkitt lymphoma N Thomas, K Dreval, DS Gerhard, LK Hilton, JS Abramson, RF Ambinder, ... Blood 141 (8), 904-916, 2023 | 49 | 2023 |
Molecular determinants of clinical outcomes in a real-world diffuse large B-cell lymphoma population W Alduaij, B Collinge, S Ben-Neriah, A Jiang, LK Hilton, M Boyle, ... Blood, The Journal of the American Society of Hematology 141 (20), 2493-2507, 2023 | 44 | 2023 |
The NIMA-related kinase NEK1 cycles through the nucleus LK Hilton, MC White, LM Quarmby Biochemical and biophysical research communications 389 (1), 52-56, 2009 | 31 | 2009 |
Characterization of DLBCL with a PMBL gene expression signature G Duns, E Viganò, D Ennishi, C Sarkozy, SS Hung, E Chavez, K Takata, ... Blood, The Journal of the American Society of Hematology 138 (2), 136-148, 2021 | 29 | 2021 |
A Forward Genetic Screen and Whole Genome Sequencing Identify Deflagellation Defective Mutants in Chlamydomonas, Including Assignment of ADF1 as a TRP … LK Hilton, F Meili, PD Buckoll, JC Rodriguez-Pike, CP Choutka, ... G3: Genes, Genomes, Genetics 6 (10), 3409-3418, 2016 | 22 | 2016 |
Notch activation is pervasive in SMZL and uncommon in DLBCL: implications for Notch signaling in B-cell tumors V Shanmugam, JW Craig, LK Hilton, MH Nguyen, CK Rushton, ... Blood Advances 5 (1), 71-83, 2021 | 20 | 2021 |
Genetic subdivisions of follicular lymphoma defined by distinct coding and noncoding mutation patterns K Dreval, LK Hilton, M Cruz, H Shaalan, S Ben-Neriah, M Boyle, ... Blood 142 (6), 561-573, 2023 | 19 | 2023 |
Relapse timing is associated with distinct evolutionary dynamics in diffuse large B-cell lymphoma LK Hilton, HS Ngu, B Collinge, K Dreval, S Ben-Neriah, CK Rushton, ... Journal of Clinical Oncology 41 (25), 4164-4177, 2023 | 18 | 2023 |
Characterization of the genetic landscape of high‐grade b‐cell lymphoma, nos–An llmpp project BJ Collinge, LK Hilton, J Wong, S Ben‐Neriah, CK Rushton, GW Slack, ... Hematological Oncology 39, 2021 | 17 | 2021 |
Single-cell profiling reveals a memory B cell-like subtype of follicular lymphoma with increased transformation risk X Wang, M Nissen, D Gracias, M Kusakabe, G Simkin, A Jiang, G Duns, ... Nature Communications 13 (1), 6772, 2022 | 12 | 2022 |
Molecular attributes underlying central nervous system and systemic relapse in diffuse large B-cell lymphoma K Isaev, D Ennishi, L Hilton, B Skinnider, KL Mungall, AJ Mungall, ... Haematologica 106 (5), 1466, 2021 | 12 | 2021 |
Prognostic significance of FCGR2B expression for the response of DLBCL patients to rituximab or obinutuzumab treatment M Nowicka, LK Hilton, M Ashton-Key, CE Hargreaves, C Lee, R Foxall, ... Blood advances 5 (15), 2945-2957, 2021 | 9 | 2021 |
Exploiting the fibroblast growth factor receptor-1 vulnerability to therapeutically restrict the MYC-EZH2-CDKN1C axis-driven proliferation in Mantle cell lymphoma A Sircar, S Singh, ZY Xu-Monette, KM Coyle, LK Hilton, E Chavdoula, ... Leukemia 37 (10), 2094-2106, 2023 | 5 | 2023 |
Risk of central nervous system involvement in high-grade B-cell lymphoma with MYC and BCL2 rearrangements: analysis of a population-based cohort with routine fluorescence in … W Alduaij, A Jiang, D Villa, B Collinge, S Ben-Neriah, M Boyle, ... Blood 140 (Supplement 1), 1332-1333, 2022 | 5 | 2022 |